NASDAQ: MBX
Mbx Biosciences Inc Stock

$10.41+1.42 (+15.8%)
Updated Feb 14, 2025
MBX Price
$10.41
Fair Value Price
N/A
Market Cap
$347.88M
52 Week Low
$8.63
52 Week High
$27.50
P/E
N/A
P/B
1.28x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.04
Operating Cash Flow
N/A
Beta
1.74
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MBX Overview

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial designed as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies designed as a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist prodrug for treating obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MBX's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
MBX
Ranked
#341 of 561

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important MBX news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MBX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MBX is good value based on its book value relative to its share price (1.28x), compared to the US Biotechnology industry average (4.77x)
P/B vs Industry Valuation
MBX's short-term assets ($281.17M) exceed its short-term liabilities ($10.92M)
Short-term Liabilities Financials
MBX's short-term assets ($281.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more MBX due diligence checks available for Premium users.

Valuation

MBX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.28x
Industry
4.77x
MBX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MBX's financial health

Profit margin

Revenue
$0.0
Net Income
-$18.1M
Profit Margin
0%

Assets to liabilities

Assets
$282.4M
Liabilities
$11.0M
Debt to equity
0.04
MBX's short-term assets ($281.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MBX's short-term assets ($281.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MBX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$14.7M
Investing
-$100.8M
Financing
$235.8M

MBX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MBXD$347.88M+15.80%N/A1.28x
CDXSC$350.74M+5.12%-4.95x4.78x
TERNC$344.85M-0.49%-3.44x0.95x
TRMLD$354.64M+5.65%-34.58x1.10x
FHTXC$340.79M-0.49%-3.19x-12.05x

Mbx Biosciences Stock FAQ

What is Mbx Biosciences's quote symbol?

(NASDAQ: MBX) Mbx Biosciences trades on the NASDAQ under the ticker symbol MBX. Mbx Biosciences stock quotes can also be displayed as NASDAQ: MBX.

If you're new to stock investing, here's how to buy Mbx Biosciences stock.

What is the 52 week high and low for Mbx Biosciences (NASDAQ: MBX)?

(NASDAQ: MBX) Mbx Biosciences's 52-week high was $27.50, and its 52-week low was $8.63. It is currently -62.15% from its 52-week high and 20.61% from its 52-week low.

How much is Mbx Biosciences's stock price per share?

(NASDAQ: MBX) Mbx Biosciences stock price per share is $10.41 today (as of Feb 14, 2025).

What is Mbx Biosciences's Market Cap?

(NASDAQ: MBX) Mbx Biosciences's market cap is $347.88M, as of Feb 18, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mbx Biosciences's market cap is calculated by multiplying MBX's current stock price of $10.41 by MBX's total outstanding shares of 33,417,418.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.